Background Background Prevalence of physical
Prevalence of physical comorbidity in severe mental illness is a comorbidity in severe mental illness is a significant public health concern, but significant public health concern, but comparative data in people with diagnoses comparative data in people with diagnoses other than schizophrenia are sparse. other than schizophrenia are sparse.
Aims Aims To investigate the prevalence of
To investigate the prevalence of metabolic disease and cardiovascular risk metabolic disease and cardiovascular risk in people with severe mental illness in people with severe mental illness treated with antipsychotics in the treated with antipsychotics in the community. community.
Methods Methods Case^control study of 90
Case^control study of 90 people treated with antipsychotics in the people treated with antipsychotics in the community and 92 age-and gendercommunity and 92 age-and gendermatched controls.The prevalence of matched controls.The prevalence of metabolic syndrome and10 -year metabolic syndrome and10 -year cardiovascular risk were calculated. cardiovascular risk were calculated.
Results

Results People on antipsychotics had a
People on antipsychotics had a significantly worse metabolic profile than significantly worse metabolic profile than controls ( controls (F F¼6.583, d.f. 6.583, d.f.¼15,161, 15,161, P P5 50.0001) .Moreover, metabolic 0.0001). Moreover, metabolic syndrome was more prevalent (OR syndrome was more prevalent (OR¼3.68, 3.68, 95% CI1.71^7.93, 95% CI1.71^7.93, P P¼0.001), as was 0.001), as was cardiovascular risk across a number of cardiovascular risk across a number of outcomes.These results are consistent outcomes.These results are consistent across diagnostic groups. across diagnostic groups.
Conclusions Conclusions People with severe
People with severe mental illness treated with antipsychotics mental illness treated with antipsychotics have excess metabolic dysfunction and have excess metabolic dysfunction and heightened risk for cardiovascular disease. heightened risk for cardiovascular disease.
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Severe mental illness is associated with a Severe mental illness is associated with a significant excess of physical comorbidity significant excess of physical comorbidity and mortality (Brown 1997; Phelan and mortality (Brown 1997; Phelan et al, et al, 2001; Osborn 2001; Osborn et al, et al, 2007) , and as such 2007), and as such represents a major public health concern. represents a major public health concern. Although suicide is prevalent in this popuAlthough suicide is prevalent in this population, ischaemic heart disease, not suicide, lation, ischaemic heart disease, not suicide, may be the major contributor to excess may be the major contributor to excess mortality (Lawrence mortality (Lawrence et al, et al, 2003) . Recently 2003) . Recently published UK guidelines on the managepublished UK guidelines on the management of schizophrenia (National Institute ment of schizophrenia (National Institute for Clinical Excellence, 2002) and bipolar for Clinical Excellence, 2002) and bipolar disorder (National Institute for Clinical disorder (National Institute for Clinical Excellence, 2006) recognise the impact of Excellence, 2006) recognise the impact of physical comorbidity in these disorders, as physical comorbidity in these disorders, as well as the paucity of high-quality research well as the paucity of high-quality research in this field. in this field.
A number of recent studies have quanti-A number of recent studies have quantified the risk of coronary heart disease, fied the risk of coronary heart disease, based on Framingham risk estimates, in based on Framingham risk estimates, in people with severe mental illness (Goff people with severe mental illness (Goff et et al, al, 2005; Correll 2005; Correll et al, et al, 2006; Osborn 2006; Osborn et al, et al, 2006) , but these have focused on those with 2006), but these have focused on those with a diagnosis of schizophrenia or non-affeca diagnosis of schizophrenia or non-affective psychoses (Goff tive psychoses (Goff et al, et al, 2005; Osborn 2005; Osborn et al, et al, 2006) and hospital in-patients 2006) and hospital in-patients (Correll (Correll et al, et al, 2006) . In this study we deter-2006) . In this study we determined the prevalence of metabolic dysfuncmined the prevalence of metabolic dysfunction and estimates of cardiovascular risk in tion and estimates of cardiovascular risk in a community sample from secondary care a community sample from secondary care of people with severe mental illness from of people with severe mental illness from across the diagnostic spectrum, who were across the diagnostic spectrum, who were taking antipsychotics, and compared the taking antipsychotics, and compared the results with those from age-and genderresults with those from age-and gendermatched controls. matched controls.
METHOD METHOD Pariticpants Pariticpants
Patients from all secondary care community Patients from all secondary care community mental health services from across the formental health services from across the former Newcastle, North Tyneside and Northmer Newcastle, North Tyneside and Northumberland Mental Health NHS Trust, and umberland Mental Health NHS Trust, and the Regional Affective Disorders Tertiary the Regional Affective Disorders Tertiary Service were invited to participate in a Service were invited to participate in a baseline study of metabolic dysfunction baseline study of metabolic dysfunction between January 2002 and March 2004 . between January 2002 and March 2004 Participants were recruited irrespective of Participants were recruited irrespective of psychiatric diagnosis. Inclusion criteria psychiatric diagnosis. Inclusion criteria were a psychiatric diagnosis and the prewere a psychiatric diagnosis and the prescription of and adherence to (determined scription of and adherence to (determined by self-report) antipsychotic medication by self-report) antipsychotic medication for a minimum of 6 months. People with for a minimum of 6 months. People with a known diagnosis of type 1 or type 2 diaa known diagnosis of type 1 or type 2 diabetes mellitus, anorexia nervosa, bulimia betes mellitus, anorexia nervosa, bulimia nervosa, neoplastic disease or alcohol denervosa, neoplastic disease or alcohol dependence were excluded. We invited 198 pendence were excluded. We invited 198 people to participate and 106 (54%) gave people to participate and 106 (54%) gave their informed consent. Baseline charactertheir informed consent. Baseline characteristics of this cohort have been described istics of this cohort have been described previously (Mackin previously (Mackin et al, et al, 2005) . 2005). All participants with a baseline assessAll participants with a baseline assessment of metabolic function were invited ment of metabolic function were invited to participate in a follow-up study between to participate in a follow-up study between June and December 2005. An age-and June and December 2005. An age-and gender-matched control group was regender-matched control group was recruited between January and June 2006 cruited between January and June 2006 for comparison of metabolic and cardiovasfor comparison of metabolic and cardiovascular risk parameters. In an attempt to concular risk parameters. In an attempt to control for demographic and socio-economic trol for demographic and socio-economic variables, family members and carers were variables, family members and carers were invited to participate as controls, and invited to participate as controls, and advertisements for volunteers were placed advertisements for volunteers were placed in local facilities within the geographical in local facilities within the geographical environs in which the community mental environs in which the community mental health teams were based. People with a hishealth teams were based. People with a history of psychiatric disorder and those who tory of psychiatric disorder and those who had ever taken a prescribed drug for a had ever taken a prescribed drug for a psychiatric disorder were excluded. All psychiatric disorder were excluded. All participants gave written informed consent participants gave written informed consent and the study was approved by the Newcastle and the study was approved by the Newcastle local research ethics committee. local research ethics committee.
Procedures Procedures
Participants were given written instructions Participants were given written instructions to fast overnight on the day before assessto fast overnight on the day before assessment, and were asked to confirm their ment, and were asked to confirm their fasting status on the morning of study. All fasting status on the morning of study. All assessments were performed in the assessments were performed in the Department of Psychiatry, University of Department of Psychiatry, University of Newcastle upon Tyne between 08.30 and Newcastle upon Tyne between 08.30 and 10.00 h on the study day. Demographic de-10.00 h on the study day. Demographic details of age, gender and ethnic group were tails of age, gender and ethnic group were obtained. Current and previous tobacco, obtained. Current and previous tobacco, alcohol and illicit substance use were alcohol and illicit substance use were recorded, as well as any history of cardiorecorded, as well as any history of cardiovascular disease and diabetes mellitus in vascular disease and diabetes mellitus in first-degree relatives. Information regarding first-degree relatives. Information regarding psychiatric diagnosis, duration of illness, psychiatric diagnosis, duration of illness, number of admissions to psychiatric innumber of admissions to psychiatric inpatients facilities, medication (including patients facilities, medication (including non-psychotropic drugs) and dosage was non-psychotropic drugs) and dosage was recorded and confirmed, where necessary, recorded and confirmed, where necessary, by reference to case notes and general by reference to case notes and general practitioner records. practitioner records.
Height, weight, and waist and hip cirHeight, weight, and waist and hip circumference were recorded using standardcumference were recorded using standardised procedures. Body mass index (BMI) ised procedures. Body mass index (BMI) and waist-to-hip ratio were calculated. and waist-to-hip ratio were calculated. Conventional BMI categories were used Conventional BMI categories were used (underweight (underweight 5 518.5; normal 18.5-24.9; 18.5; normal 18.5-24.9; overweight 25.0-29.9 ; obese: overweight 25.0-29.9; obese: 4 430.0). 30.0). Blood pressure was recorded using a sphygBlood pressure was recorded using a sphygmomanometer on three occasions during momanometer on three occasions during the assessment, and the value expressed as the assessment, and the value expressed as the mean of the three recordings. A 12-lead the mean of the three recordings. A 12-lead electrocardiogram (ECG) was recorded at electrocardiogram (ECG) was recorded at 50 mm/s using a MAC 1200ST portable 50 mm/s using a MAC 1200ST portable machine (GE Medical Systems, Slough, machine (GE Medical Systems, Slough, Berkshire, UK). For the purposes of cardioBerkshire, UK Levy et al, et al, 1998) was used to assess glucose handling, 1998) was used to assess glucose handling, which is expressed as pancreatic beta-cell which is expressed as pancreatic beta-cell function, insulin sensitivity and insulin refunction, insulin sensitivity and insulin resistance. Values for these parameters were sistance. Values for these parameters were based on fasting glucose and insulin levels based on fasting glucose and insulin levels and calculated using the HOMA Calculaand calculated using the HOMA Calculator, version 2.2 (Diabetes Trial Unit, Unitor, version 2.2 (Diabetes Trial Unit, University of Oxford, UK). The model is versity of Oxford, UK). The model is calibrated to give beta-cell function and calibrated to give beta-cell function and insulin sensitivity of 100% in healthy adults insulin sensitivity of 100% in healthy adults with currently available insulin assays. with currently available insulin assays. Impaired fasting glucose was defined as Impaired fasting glucose was defined as fasting blood glucose between 6.1 and fasting blood glucose between 6.1 and 7.0 mmol/l, and diabetes mellitus as fasting 7.0 mmol/l, and diabetes mellitus as fasting blood glucose blood glucose 5 57.0 mmol/l (National Dia-7.0 mmol/l (National Diabetes Data Group, 1979) . The presence of betes Data Group, 1979) . The presence of the metabolic syndrome was based on the the metabolic syndrome was based on the definition by the International Diabetes definition by the International Diabetes Federation (Alberti Federation (Alberti et al, et al, 2006 ac.uk/calculator.htm) was used to compute ac.uk/calculator.htm) was used to compute percentage risk estimates for a number of percentage risk estimates for a number of outcomes over a 10-year period. Risk estioutcomes over a 10-year period. Risk estimates using the Framingham equation have mates using the Framingham equation have important differences from the JBS definiimportant differences from the JBS definition which include the ability to calculate tion which include the ability to calculate specific risks (for cardiovascular disease, specific risks (for cardiovascular disease, coronary heart disease, myocardial infarccoronary heart disease, myocardial infarction, stroke, death due to cardiovascular tion, stroke, death due to cardiovascular disease and death due to coronary heart disdisease and death due to coronary heart disease) and the option to vary the time period ease) and the option to vary the time period over which risk is computed. Cardiovascuover which risk is computed. 
RESULTS RESULTS
Characteristics of participants Characteristics of participants
Of the original 106 participants in the Of the original 106 participants in the baseline study, 90 (85%) consented to baseline study, 90 (85%) consented to participate in the current study; 6 (5.7%) participate in the current study; 6 (5.7%) did not reply to the invitation; 6 (5.7%) redid not reply to the invitation; 6 (5.7%) refused to consent; 2 (1.9%) were too unwell fused to consent; 2 (1.9%) were too unwell to participate; and 1 (1%) denied having to participate; and 1 (1%) denied having participated in the original study. Characparticipated in the original study. Characteristics of the participants with mental illteristics of the participants with mental illness and the 92 controls are given in ness and the 92 controls are given in Table 1 . The groups were well matched in Table 1 . The groups were well matched in terms of age and gender. Participants with terms of age and gender. Participants with mental illness were recruited from across mental illness were recruited from across the diagnostic spectrum: bipolar disorder the diagnostic spectrum: bipolar disorder ( (n n¼32, 35.6%); schizophrenia ( 32, 35.6%); schizophrenia (n n¼27, 27, 30.0%); schizoaffective disorder ( 30.0%); schizoaffective disorder (n n¼9, 9, 10.0%); other (including delusional, 10.0%); other (including delusional, 2 4 2 4 AUTHOR'S PROOF AUTHOR'S PROOF 
Medication Medication
Of the 90 people with mental illness who Of the 90 people with mental illness who participated in this study, 83 (92%) were participated in this study, 83 (92%) were still receiving antipsychotic medication; 71 still receiving antipsychotic medication; 71 (86%) were receiving one antipsychotic (86%) were receiving one antipsychotic drug and 12 (14%) were prescribed combidrug and 12 (14%) were prescribed combination antipsychotic medication. Of those nation antipsychotic medication. Of those taking just one antipsychotic, 16 (23%) taking just one antipsychotic, 16 (23%) were taking a typical agent and 55 (77%) were taking a typical agent and 55 (77%) an atypical. Details of antipsychotic and an atypical. Details of antipsychotic and other medication are given in Table 2 . other medication are given in Table 2 .
Metabolic parameters Metabolic parameters
Metabolic parameters for participants with Metabolic parameters for participants with mental illness and controls are given in mental illness and controls are given in Table 3 . From the MANCOVA model, and serum insulin were all significantly and serum insulin were all significantly higher in those with mental ilness than higher in those with mental ilness than controls. Moreover, HDL cholesterol controls. Moreover, HDL cholesterol (which is cardioprotective) was signifi-(which is cardioprotective) was significantly lower. Estimation of insulin sensitivcantly lower. Estimation of insulin sensitivity and insulin resistance by HOMA ity and insulin resistance by HOMA revealed differences between the two revealed differences between the two groups; that is people with mental illness groups; that is people with mental illness were more insulin resistant, more had diswere more insulin resistant, more had disorders of glucose homeostasis compared orders of glucose homeostasis compared with controls (14.4 with controls (14.4 v.
v. 1.1%, 1.1%, P P¼0.003), 0.003), and there was a higher prevalence of the and there was a higher prevalence of the metabolic syndrome (33.3 metabolic syndrome (33.3 v.
v. 11.9%, 11.9%, P P¼0.001). There were no differences in 0.001). There were no differences in either systolic or diastolic blood pressure either systolic or diastolic blood pressure between the groups. between the groups.
Cardiovascular risk Cardiovascular risk
Ten-year risk estimates based on the JBS Ten-year risk estimates based on the JBS definition of cardiovascular disease and definition of cardiovascular disease and the Framingham cardiovascular outcome the Framingham cardiovascular outcome risk estimates are given in Table 4 . The risk risk estimates are given in Table 4 . The risk calculator allows estimation of risk for calculator allows estimation of risk for people between 35 and 75 years of age people between 35 and 75 years of age (participants with mental illness (participants with mental illness n n¼72; 72; controls controls n n¼65). Figure 1 represents the 65). Figure 1 represents the differences in cardiovascular outcome risks differences in cardiovascular outcome risks between the two groups. between the two groups.
Participants with mental illness had Participants with mental illness had statistically greater mean 10-year risk estistatistically greater mean 10-year risk estimates than controls for all outcomes with mates than controls for all outcomes with the exception of stroke (but there was a stathe exception of stroke (but there was a statistical trend towards a greater 10-year risk tistical trend towards a greater 10-year risk for stroke). Those people with a 10-year for stroke). Those people with a 10-year risk of cardiovascular disease according to risk of cardiovascular disease according to the JBS definition of greater than or equal the JBS definition of greater than or equal to 20% or those with established disease to 20% or those with established disease and/or diabetes mellitus should be considand/or diabetes mellitus should be considered 'high risk'. ered 'high risk'.
Effect of smoking Effect of smoking
Significantly more participants with mental Significantly more participants with mental illness than controls smoked tobacco. Uniillness than controls smoked tobacco. Univariate ANOVA was used to examine the variate ANOVA was used to examine the interaction between smoking status, metainteraction between smoking status, metabolic and cardiovascular risk parameters. bolic and cardiovascular risk parameters. 
Effect of diagnosis Effect of diagnosis
The impact of diagnostic group on metaThe impact of diagnostic group on metabolic and cardiovascular risk was examined. bolic and cardiovascular risk was examined. All metabolic and cardiovascular risk All metabolic and cardiovascular risk parameters were entered into a one-way parameters were entered into a one-way ANOVA with diagnostic group (bipolar ANOVA with diagnostic group (bipolar disorder, schizophrenia, schizoaffective disdisorder, schizophrenia, schizoaffective disorder, other) as the factor in the model. order, other) as the factor in the model. There were no statistical differences in There were no statistical differences in any of the variables between diagnostic any of the variables between diagnostic groups. groups.
Effect of antipsychotic treatment Effect of antipsychotic treatment
In order to investigate the interaction beIn order to investigate the interaction between the type of antipsychotic treatment tween the type of antipsychotic treatment (i.e. no treatment, atypical, typical or com-(i.e. no treatment, atypical, typical or combination) and metabolic/cardiovascular risk bination) and metabolic/cardiovascular risk parameters, all variables were entered into parameters, all variables were entered into a one-way ANOVA with treatment group a one-way ANOVA with treatment group as the factor in the model. Serum insulin as the factor in the model. Serum insulin was significantly higher in participants was significantly higher in participants taking atypical agents compared with all taking atypical agents compared with all other groups ( other groups
.f.¼3,173, 3,173, P P¼0.04). There were no other statistically 0.04). There were no other statistically significant differences between treatment significant differences between treatment groups. groups.
Treatment of metabolic Treatment of metabolic dysfunction and cardiovascular dysfunction and cardiovascular risk factors risk factors
The proportion of patients receiving approThe proportion of patients receiving appropriate pharmacological treatment for priate pharmacological treatment for cardiovascular risk factors (hypertension cardiovascular risk factors (hypertension and dyslipidaemia) was examined. and dyslipidaemia) was examined.
2 5 2 5 AUTHOR'S PROOF AUTHOR'S PROOF 
Dyslipidaemia Dyslipidaemia
Current recommendations state that treatCurrent recommendations state that treatment of dyslipidaemia should be based on ment of dyslipidaemia should be based on an overall assessment of risk rather than an overall assessment of risk rather than an isolated serum lipid value. However, an isolated serum lipid value. However, 'high-risk' patients should be offered pro-'high-risk' patients should be offered prophylactic lipid-lowering therapy. Of the phylactic lipid-lowering therapy. Of the 13 high-risk patients, only 4 (30.8%) were 13 high-risk patients, only 4 (30.8%) were receiving lipid-lowering therapy. One receiving lipid-lowering therapy. One control participant was considered to be control participant was considered to be 'high risk' and was receiving appropriate 'high risk' and was receiving appropriate therapy. therapy.
Hypertension Hypertension
Hypertension was considered to be present Hypertension was considered to be present if systolic blood pressure was if systolic blood pressure was 5 5135 mmHg 135 mmHg and/or diastolic blood pressure was and/or diastolic blood pressure was 5 585 mmHg (Alberti 85 mmHg . Fifteen 2006). Fifteen participants with mental illness (16.7%) participants with mental illness (16.7%) met criteria for hypertension compared with met criteria for hypertension compared with 13 controls (14.1%). Nine participants 13 controls (14.1%). Nine participants with mental illness and hypertension with mental illness and hypertension (60%) were not receiving an antihyperten-(60%) were not receiving an antihypertensive agent, compared with 10 controls with sive agent, compared with 10 controls with hypertension (77%). hypertension (77%).
DISCUSSION DISCUSSION
Current research is increasingly adding to Current research is increasingly adding to the weight of evidence that the burden of the weight of evidence that the burden of physical comorbidity is greater in people physical comorbidity is greater in people with severe mental illness. Studies investiwith severe mental illness. Studies investigating the prevalence of metabolic dysfuncgating the prevalence of metabolic dysfunction and cardiovascular risk have focused tion and cardiovascular risk have focused largely on people with schizophrenia, and largely on people with schizophrenia, and comparative data in other diagnostic comparative data in other diagnostic groups are sparse. groups are sparse.
Main findings Main findings
The current study sought to investigate The current study sought to investigate markers of metabolic dysfunction and markers of metabolic dysfunction and cardiovascular risk estimates in a diagnosticardiovascular risk estimates in a diagnostically heterogeneous sample of people with cally heterogeneous sample of people with severe mental illness treated in the comsevere mental illness treated in the community. Compared with controls, people munity. Compared with controls, people with mental illness, irrespective of diagnosis, with mental illness, irrespective of diagnosis, had a significantly higher BMI (the mean had a significantly higher BMI (the mean BMI of 29.9 being within the overweight BMI of 29.9 being within the overweight category and marginally short of the obese), category and marginally short of the obese), waist circumference and waist-to-hip ratio waist circumference and waist-to-hip ratio (reflecting increased visceral adiposity). Dys-(reflecting increased visceral adiposity). Dyslipidaemias and disorders of glucose homeoslipidaemias and disorders of glucose homeostasis were more prevalent, as was the tasis were more prevalent, as was the metabolic syndrome diagnosed according to metabolic syndrome diagnosed according to the definition of the International Diabetes the definition of the International Diabetes Federation (Alberti Federation (Alberti et al, et al, 2006) . The mean 2006). The mean 10-year risk for cardiovascular disease (esti-10-year risk for cardiovascular disease (estimated according to both British and Framated according to both British and Framingham definitions) and the risk for a mingham definitions) and the risk for a number of cardiovascular outcomes, includnumber of cardiovascular outcomes, including myocardial infarction and death due to ing myocardial infarction and death due to cardiovascular disease, were consistently cardiovascular disease, were consistently higher in participants with mental illness higher in participants with mental illness compared with controls. Moreover, a high compared with controls. Moreover, a high proportion of people whose level of cardioproportion of people whose level of cardiovascular risk exceeds the threshold for intervascular risk exceeds the threshold for intervention are not receiving appropriate vention are not receiving appropriate treatment. treatment.
Other studies Other studies
Osborne Osborne et al et al (2006) reported raised 10-(2006) reported raised 10-year coronary heart disease risk scores year coronary heart disease risk scores (based on Framingham criteria), HDL (based on Framingham criteria), HDL cholesterol levels, total cholesterol level cholesterol levels, total cholesterol level and an increased prevalence of diabetes and an increased prevalence of diabetes mellitus in a sample of people with schizomellitus in a sample of people with schizophrenia or non-affective psychoses from phrenia or non-affective psychoses from primary care. Another study has also reprimary care. Another study has also reported increased 10-year cardiac risk in ported increased 10-year cardiac risk in people with schizophrenia from the Clinical people with schizophrenia from the Clinical Antipsychotic Antipsychotic Trials of Intervention EffecTrials of Intervention Effectiveness (CATIE) tiveness (CATIE) study (Goff study (Goff et al, et al, 2005 (2006) studied the prevalence of the metabolic syndrome and 10-year risk of the metabolic syndrome and 10-year risk of coronary heart disease in psychiatric inof coronary heart disease in psychiatric inpatients from across the diagnostic specpatients from across the diagnostic spectrum receiving atypical antipsychotics. trum receiving atypical antipsychotics. Thirty-seven per cent of patients in this Thirty-seven per cent of patients in this sample met National Cholesterol Education sample met National Cholesterol Education Program criteria for metabolic syndrome, Program criteria for metabolic syndrome, and 47% fulfilled International Diabetes and 47% fulfilled International Diabetes Federation criteria (Correll Federation criteria (Correll et al, et al, 2006 (Correll et al, et al, ). 2006 ). This study lacked a control group, and This study lacked a control group, and although the prevalence of defined metaalthough the prevalence of defined metabolic syndrome was higher than in our bolic syndrome was higher than in our study, differences in participant characterisstudy, differences in participant characteristics (i.e. we studied community out-patients tics (i.e. we studied community out-patients treated with typical and atypical antipsytreated with typical and atypical antipsychotics), and a greater overall prevalence chotics), and a greater overall prevalence of obesity and the metabolic syndrome in of obesity and the metabolic syndrome in 2 6 2 6 AUTHOR'S PROOF AUTHOR'S PROOF Underweight, Underweight, n n (%)
Normal, Normal, n n (%)
Overweight, Overweight, n n (%)
Obese, Obese, n n (%) (%) 29.9 (4.9)*** 29.9 (4.9)*** 
Strengths of our study Strengths of our study
Our findings confirm the results of several Our findings confirm the results of several other studies, and offer further insights into other studies, and offer further insights into the nature of metabolic disease and cardiothe nature of metabolic disease and cardiovascular disease risk in severe mental vascular disease risk in severe mental illness. The inclusion of a diagnostically illness. The inclusion of a diagnostically heterogeneous sample is important in terms heterogeneous sample is important in terms of understanding the effect of diagnosis on of understanding the effect of diagnosis on the development of metabolic dysfunction the development of metabolic dysfunction and cardiovascular risk. The problem of and cardiovascular risk. The problem of physical comorbidity and strategies for physical comorbidity and strategies for improving physical health in schizophrenia improving physical health in schizophrenia have been addressed previously (Marder have been addressed previously (Marder et al, et al, 2004) . However, research in other 2004). However, research in other psychiatric disorders such as bipolar psychiatric disorders such as bipolar disorders, lags behind (Clement disorders, lags behind (Clement et al, et al, 2003) and there is an urgent need to estab-2003) and there is an urgent need to establish whether there is a similar pattern of lish whether there is a similar pattern of physical comorbidity. A high prevalence physical comorbidity. A high prevalence of metabolic syndrome and cardiovascular of metabolic syndrome and cardiovascular risk in psychiatric in-patients from across risk in psychiatric in-patients from across the diagnostic spectrum has recently been the diagnostic spectrum has recently been reported (Correll reported (Correll et al, et al, 2006) , and we con-2006), and we confirm these findings in a sample of comfirm these findings in a sample of community out-patients treated with typical munity out-patients treated with typical and atypical antipsychotics. and atypical antipsychotics.
Investigating metabolic dysfunction in a Investigating metabolic dysfunction in a community out-patient sample overcomes, community out-patient sample overcomes, to some extent, the confounding impact of to some extent, the confounding impact of physical inactivity on glucose homeostasis physical inactivity on glucose homeostasis (Fulton-Kehoe (Fulton-Kehoe et al, et al, 2001) which is 2001) which is inherent in studies of psychiatric in-patients inherent in studies of psychiatric in-patients (Martinsen (Martinsen et al, et al, 1989) . All our participants 1989). All our participants were considered to be clinically stable, and were considered to be clinically stable, and thus the confounding influence on metathus the confounding influence on metabolic function of acute stress resulting from bolic function of acute stress resulting from psychosis (Shiloah psychosis (Shiloah et al, et al, 2003) or other dis-2003) or other distressing psychiatric symptoms was avoided. tressing psychiatric symptoms was avoided.
Unlike previous studies investigating Unlike previous studies investigating metabolic disease and cardiovascular risk, metabolic disease and cardiovascular risk, we also measured serum insulin and calcuwe also measured serum insulin and calculated insulin sensitivity and beta-cell funclated insulin sensitivity and beta-cell function using the HOMA. Serum insulin and tion using the HOMA. Serum insulin and insulin resistance, both established indepeninsulin resistance, both established independent risk factors for cardiovascular disease dent risk factors for cardiovascular disease (Reaven, 2002) , were increased in partici- (Reaven, 2002) , were increased in participants with mental illness. However, the pants with mental illness. However, the mechanism underpinning the pathophysiolmechanism underpinning the pathophysiology of insulin resistance in severe mental ogy of insulin resistance in severe mental illness is poorly understood. illness is poorly understood.
Although much of the current literature Although much of the current literature focuses on the risk of metabolic dysregulafocuses on the risk of metabolic dysregulation in people taking atypical antipsychotics, tion in people taking atypical antipsychotics, significant numbers of people continue to significant numbers of people continue to take first-generation agents. Our study take first-generation agents. Our study was designed to gather data on metabolic was designed to gather data on metabolic dysfunction and cardiovascular risk in a dysfunction and cardiovascular risk in a typical clinical setting. Although the study typical clinical setting. Although the study was not designed or powered to investigate was not designed or powered to investigate the contribution of specific antipsychotic the contribution of specific antipsychotic drugs, or classes of drugs, to metabolic or drugs, or classes of drugs, to metabolic or cardiovascular disease, with the exception cardiovascular disease, with the exception of serum insulin levels, which were signifiof serum insulin levels, which were significantly higher in people taking atypical cantly higher in people taking atypical antipsychotics, the metabolic and cardioantipsychotics, the metabolic and cardiovascular risk profiles were similar in those vascular risk profiles were similar in those taking typical, atypical or no antipsychotic taking typical, atypical or no antipsychotic medication. However, the small sample medication. However, the small sample who were not receiving antipsychotic mediwho were not receiving antipsychotic medication at the time of investigation had precation at the time of investigation had previously been prescribed an antipsychotic viously been prescribed an antipsychotic drug; any impact of this drug on metabolic drug; any impact of this drug on metabolic function might have continued after the function might have continued after the drug was no longer prescribed. drug was no longer prescribed.
A further unique contribution of this A further unique contribution of this study is the estimation of a number of study is the estimation of a number of cardiovascular outcomes. There is a strikcardiovascular outcomes. There is a striking and consistent difference in cardioing and consistent difference in cardiovascular risk across a number of domains vascular risk across a number of domains between people with mental illness and between people with mental illness and controls. Cardiovascular risk estimates controls. Cardiovascular risk estimates were based on robust models derived from were based on robust models derived from the JBS and the Framingham risk charts. the JBS and the Framingham risk charts. These are frequently used by physicians to These are frequently used by physicians to guide management of high-risk patients guide management of high-risk patients and to assist in decisions regarding interand to assist in decisions regarding intervention. Our data suggest that a high provention. Our data suggest that a high proportion of people with mental illness who portion of people with mental illness who are at high risk for adverse cardiovascular are at high risk for adverse cardiovascular 2 7 2 7 AUTHOR'S PROOF AUTHOR'S PROOF 
9.3 (10.5)** 9.3 (10.5)** 41 (56.9)* 41 (56.9)* 23 (31.9)* 23 (31.9)* 7 (9.7)** 7 (9.7)** 4.7 (4.3) 4.7 (4.3)
26 (40) 26 (40) 10 (15.3) 10 (15.3)
4.1 (5.6)*** 4.1 (5.6)*** 22 (30.6)** 22 (30.6)** 9 (12.5)* 9 (12.5)* 2 (2.7) 2 (2.7)
1.8 (2.2) 1.8 (2.2) 6 (9.2) 6 (9.2) 1 (1.5) 1 (1.5)
1.7 (3.2) 1.7 (3.2) 5 (6.9) 5 (6.9)
Risk of death due to CVD: mean (s.d.) Risk of death due to CVD: mean (s.d.) events are not offered appropriate prophyevents are not offered appropriate prophylactic intervention. This is in keeping with lactic intervention. This is in keeping with another recent study that has reported low another recent study that has reported low rates of treatment for hypertension, dyslipirates of treatment for hypertension, dyslipidaemia and diabetes in people with schizodaemia and diabetes in people with schizophrenia from the CATIE trial (Nasrallah phrenia from the CATIE trial (Nasrallah et et al, al, 2006 (Nasrallah et et al, al, ). 2006 ).
Limitations of the study Limitations of the study
Although we did not detect differences in Although we did not detect differences in the prevalence of metabolic disease or the prevalence of metabolic disease or estimates of cardiovascular risk across the estimates of cardiovascular risk across the diagnostic groups, the study might not have diagnostic groups, the study might not have been sufficiently powered to detect such been sufficiently powered to detect such differences. differences.
Selecting an appropriate control group Selecting an appropriate control group for studies of this nature is complex. We for studies of this nature is complex. We attempted to control for demographic charattempted to control for demographic characteristics by specifically targeting carers acteristics by specifically targeting carers and family members, and by recruiting and family members, and by recruiting controls from the geographical locale of controls from the geographical locale of participants with mental illness. This participants with mental illness. This methodology might be considered somewhat methodology might be considered somewhat crude, and as our analysis did not control for crude, and as our analysis did not control for socio-economic variables we cannot exclude socio-economic variables we cannot exclude the possibility that the disparity in rates of the possibility that the disparity in rates of metabolic disease and increased cardiovasmetabolic disease and increased cardiovascular risk estimates are attributable to cular risk estimates are attributable to differing levels of deprivation. differing levels of deprivation.
People who volunteer to participate in People who volunteer to participate in medical research may take a more active inmedical research may take a more active interest in their physical health, and thus the terest in their physical health, and thus the prevalence of metabolic dysfunction and prevalence of metabolic dysfunction and cardiovascular risk in the general popucardiovascular risk in the general population without severe mental illness might lation without severe mental illness might have been underestimated in our control have been underestimated in our control group. The existence of such a potential bias group. The existence of such a potential bias is supported by the observed low prevalence is supported by the observed low prevalence of tobacco smoking in the control group of tobacco smoking in the control group (14%) compared with the reported preva-(14%) compared with the reported prevalence in the general population. We cannot lence in the general population. We cannot exclude the possibility, however, that a simiexclude the possibility, however, that a similar selection bias occurred in the recruitment lar selection bias occurred in the recruitment of participants with mental illness: only 40% of participants with mental illness: only 40% of this group smoked, which is lower than of this group smoked, which is lower than the prevalence (51%) reported in a recent the prevalence (51%) reported in a recent large retrospective cohort study of people large retrospective cohort study of people with severe mental illness (Osborn with severe mental illness (Osborn et al et al, , 2007) . These potential sources of bias may 2007). These potential sources of bias may have resulted in an underestimate of the true have resulted in an underestimate of the true prevalence of risk in both groups. prevalence of risk in both groups.
Although most of our participants with Although most of our participants with mental illness were taking antipsychotic mental illness were taking antipsychotic medication at the time of investigation, medication at the time of investigation, the direction of causality cannot be estabthe direction of causality cannot be established. There is accumulating evidence that lished. There is accumulating evidence that antipsychotic drugs add to the metabolic antipsychotic drugs add to the metabolic burden in people with severe mental illness, burden in people with severe mental illness, but physical inactivity and diet are probably but physical inactivity and diet are probably also influential. Tobacco smoking is also a also influential. Tobacco smoking is also a well-established risk factor for cardiovascuwell-established risk factor for cardiovascular disease (Unal lar disease (Unal et al, et al, 2005) , and although 2005), and although significantly more people with mental significantly more people with mental illness smoked compared with controls, illness smoked compared with controls, differences in smoking behaviour did not differences in smoking behaviour did not account for the excess metabolic and cardiaccount for the excess metabolic and cardiovascular risk. A genetic contribution to the ovascular risk. A genetic contribution to the increased metabolic and cardiovascular risk increased metabolic and cardiovascular risk in people with severe mental illness should in people with severe mental illness should also be considered, as an increased prevaalso be considered, as an increased prevalence of type 2 diabetes mellitus has been lence of type 2 diabetes mellitus has been reported in unaffected first-degree relatives reported in unaffected first-degree relatives of people with schizophrenia (Mukherjee of people with schizophrenia (Mukherjee et al et al, 1989) . This may suggest shared loci , 1989) . This may suggest shared loci of genetic susceptibility for severe mental of genetic susceptibility for severe mental illness and diabetes, but shared environillness and diabetes, but shared environmental factors may also be important. mental factors may also be important. and controls (ö and controls (ö& &ö). CVD, cardiovascular disease; CHD, coronary heart disease; JBS, Joint British Societies. ö). CVD, cardiovascular disease; CHD, coronary heart disease; JBS, Joint British Societies.
Implications Implications
Current models of care appear to be failing Current models of care appear to be failing a large proportion of people with severe a large proportion of people with severe mental illness. The reasons for this are mental illness. The reasons for this are likely to be manifold. Use of physical likely to be manifold. Use of physical healthcare services often decreases after healthcare services often decreases after the onset of a psychiatric disorder (Jeste the onset of a psychiatric disorder (Jeste et et al, al, 1996) , and even when patients are en-1996) , and even when patients are engaged with healthcare services, rates of ungaged with healthcare services, rates of undiagnosed physical illnesses are often high diagnosed physical illnesses are often high (Mackin (Mackin et al, et al, 2005) . Other factors may 2005). Other factors may also contribute to poor detection and diagalso contribute to poor detection and diagnosis of physical illness, including impaired nosis of physical illness, including impaired ability to verbalise concerns (Lieberman & ability to verbalise concerns (Lieberman & Coburn, 1986; Massad Coburn, 1986; Massad et al, et al, 1990) , poor 1990), poor insight into illness (Massad insight into illness (Massad et al, et al, 1990) , de-1990) , denial of illness (Goldman, 1999) , or an unnial of illness (Goldman, 1999) , or an unwillingness to consult a doctor other than willingness to consult a doctor other than their psychiatrist. When people are cared their psychiatrist. When people are cared for by psychiatrists, primary care physicians for by psychiatrists, primary care physicians and physicians from other disciplines, there and physicians from other disciplines, there may be a shared assumption that a colleague may be a shared assumption that a colleague is taking responsibility for managing a partiis taking responsibility for managing a particular medical problem, when in fact the cular medical problem, when in fact the problem is not being attended to at all. problem is not being attended to at all.
There are few studies specifically examThere are few studies specifically examining the impact of differing models of care ining the impact of differing models of care on physical well-being and comorbidity in on physical well-being and comorbidity in severe mental illness. One randomised trial severe mental illness. One randomised trial from the USA evaluated an integrated modfrom the USA evaluated an integrated model of primary medical care for a cohort of el of primary medical care for a cohort of people with serious mental disorders, and people with serious mental disorders, and the authors concluded that on-site, intethe authors concluded that on-site, integrated primary care was associated with grated primary care was associated with improved quality and outcomes of medical improved quality and outcomes of medical care (Druss care (Druss et al, et al, 2001 ). Interventions such 2001). Interventions such as improving provider competencies through as improving provider competencies through education and profiling, and organisational education and profiling, and organisational interventions such as computerised remininterventions such as computerised reminders to prompt mental health professionals ders to prompt mental health professionals to refer to primary care for appropriate to refer to primary care for appropriate screening, require further investigation. screening, require further investigation.
There is a need for greater communicaThere is a need for greater communication and collaboration between primary tion and collaboration between primary and secondary care, and for the establishand secondary care, and for the establishment of clear guidelines outlining responsiment of clear guidelines outlining responsibilities and protocols for screening and bilities and protocols for screening and managing physical health and disease in peomanaging physical health and disease in people with severe mental illness. Integrated ple with severe mental illness. Integrated models of care, including mental and physimodels of care, including mental and physical health professionals, may be more approcal health professionals, may be more appropriate for delivering care to this group. priate for delivering care to this group. 
